Xiangya Hospital of Central South University
Changsha, Hunan, 410008, China
Location status: Recruiting
Location contact
Jifeng Guo, Ph.D.
CONTACT
Qiying Sun, Ph.D.
CONTACT
NCT Number: NCT03508986
The purpose of the Chinese Familial Parkinson's disease Registry (CFPDR) is to develop a database of patients with familial Parkinson's disease (PD) in China.
Interested in participating?
Request InfoAll sexes
Observational
Changsha, Hunan, 410008, China
Location status: Recruiting
Jifeng Guo, Ph.D.
CONTACT
Qiying Sun, Ph.D.
CONTACT
Parkinson's disease (PD) is the second most common disorder among degenerative neurological disease. Familial PD (FPD) has its unique clinical feature and genetic basis. We aim to establish a database of FPD,and characterize the clinical feature, genetic basis, environmental factors and their interactions FPD in China.
Method:
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 years
To collect 1500 patients with familial Parkinson's disease and establish the database of Familial Parkinson's disease (FPD) in mainland China.
Time frame: 10 years
To characterize clinical feature and environmental factors among Chinese familial parkinson's disease
Time frame: 10 years
To characterize the genetic basis of Chinese FPD and detect clinically relevant genetic variants in these cases
Contact information is provided by the study sponsor or research team.
Beisha Tang, Ph.D.
CONTACT
Jifeng Guo, Ph.D.
CONTACT
Xiangya Hospital of Central South University
Other
The Chinese Familial Parkinson's Disease Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07207122
Basal Ganglia Diseases, Brain Diseases
Santa Monica, California, United States
View Trial DetailsNCT06680830
Basal Ganglia Diseases, Brain Diseases
Sun City, Arizona, United States
View Trial DetailsNCT07323121
Basal Ganglia Diseases, Brain Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT04477785
Anosmia, Basal Ganglia Diseases
Birmingham, Alabama, United States
View Trial Details